SituationAfter the procedure
Breast screening and imaging after fat grafting
The situation
Years after breast fat grafting a person may be told that a mammogram shows calcifications or cysts, or may worry in advance that grafting will hide a tumour. The situation is about imaging: what changes fat grafting can produce, how radiologists distinguish them from suspicious findings, what the oncologic-safety literature says, and what to tell the screening centre. It applies before the procedure and at every check-up afterwards.
Common concerns: cancer anxiety · fear of misdiagnosis · regret
What people weigh in this situation
Each condition is answered with facts from the entity pages; the [n] marks lead to the source.
Imaging changes after grafting
- Listed risks
- Cysts, infection, microcalcification, death of fat cells (necrosis), and some transferred fat leaving the breast area[2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons
- Imaging note
- Fat necrosis, cysts and calcifications can appear on mammograms and must be interpreted by a radiologist[1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons
Oncologic safety evidence
- Oncologic safety evidence
- Meta-analysis of 15 studies (8,541 participants): no difference in overall survival, disease-free survival or local recurrence between patients who had fat grafting after breast cancer surgery and controls[3]journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract recordBMC Cancer (via Europe PMC)
- 2009 ASPS Fat Graft Task Force
- Concluded that the literature then available showed no association between fat grafting and higher rates of malignancy[4]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central
Complications reported with enriched grafts
- Reported safety concernsSVF Breast Augmentation
- Cyst formation 6.9% with automated vs 1.6% with manual isolation in cited data; theoretical oncogenic concern from VEGF/FGF signalling; long-term oncologic data insufficient[5]journalCell-Assisted Lipotransfer in Breast Augmentation Surgery: Clinical Outcomes and Considerations for Future ResearchCureus (via PubMed Central)
Related questions
지방이식 석회화, 왜 생기고 어떻게 확인하나요?지방이식 석회화는 이식된 지방 일부가 혈류를 얻지 못해 괴사한 뒤, 그 자리에 칼슘이 침착되면서 생길 수 있습니다. 특히 가슴 지방이식 후에는 유방 촬영이나 초음파에서 관찰될 수 있습니다. 따라서 검진 때 지방이식 병력을 알리고, 영상의학적 판독과 필요한 추가 검사를 받는 것이 권장됩니다.지방이식 멍울 및 지방이식 낭종, 생기면 어떻게 대처하나요?지방이식 멍울과 낭종은 알려진 합병증입니다. 이식된 지방 일부가 괴사하거나 녹으면서 단단한 결절이나 기름낭(oil cyst)으로 남을 때 생길 수 있습니다. 수술 초기의 부종으로 단단한 것과는 구별해야 합니다. 오래 지속되거나 커지는 멍울은 초음파 등으로 평가받고, 처치 여부는 전문의와 상의해 결정하는 것이 적절합니다.가슴 지방이식이 유방암 검진에 영향을 주나?영향을 줄 수 있습니다. 가슴 지방이식 뒤에는 지방괴사, 유낭종, 석회화가 생길 수 있고, 이는 유방 촬영 등 영상 검사에 나타납니다. 다른 소견과 구별하려면 영상의학과 전문의의 판독이 필요합니다. 검진을 받을 때는 지방이식 여부와 시기를 반드시 알리십시오. 수술 기록과 이전 영상을 보관해 두면 나중에 비교할 수 있습니다.豊胸でSVF脂肪注入を受けた場合、しこりや石灰化のリスク、乳がん検診への影響はどうなりますか？報告されている合併症のうち最も頻度が高いのは石灰化で、系統的レビューでは悪性と報告された例はありません。ただし平均追跡期間は16.2か月で、腫瘍学的な結論を出すには短いと明記されています。日本の学会がまとめた乳房への脂肪移植の治療手順では、脂肪壊死による嚢胞や石灰化が乳房画像で乳がんと紛らわしくなる場合があるとされ、長期の経過観察が必要とされています。検診の際は脂肪注入を受けた事実を必ず申告してください。SVF豊胸のあと、しこりや石灰化はできますか？帰国後の乳がん検診に影響しますか？報告はあります。40例のシリーズではMRIで12 mm未満の嚢胞が2例、術後24か月のマンモグラフィで微小石灰化が2例ありました。総説では嚢胞形成の頻度として自動分離6.9%、用手分離1.6%が引用されています。日本の学会の治療手順では、こうした所見が乳房画像で乳がんと紛らわしくなる場合があるとされ、長期の経過観察が勧められています。帰国後の検診では施術内容と時期を必ず伝えてください。수술 후 석회화나 낭종이 생기면 나중에 유방암 검진에 지장이 있나요?2008년 원 보고에서는 40명 중 MRI상 12 mm 미만 낭종 2명, 24개월 시점 유방촬영상 미세석회화 2명, 흉골 섬유화 1명이 관찰되었습니다 [1]. 문헌 고찰에서는 세포 분리 방식에 따라 낭종 형성률이 자동화 6.9%, 수기 1.6%로 인용되었습니다 [3]. 제공된 자료에는 이런 소견이 향후 유방암 검진 판독에 미치는 영향을 정량적으로 다룬 데이터가 없으므로, 검진 시 지방이식 이…
How to verify an institution
Instead of a ranking, use the public records that exist for this kind of procedure in Korea.
- Check the Ministry of Health and Welfare list of designated advanced regenerative medicine institutions for the designation number.
- Check the cell-processing facility permit register (K-ARM) when cells are isolated or processed.
- Treat case counts, success rates and "first" claims published by the institution itself as official claims until an independent record confirms them.
Institutions with a public record
Providers in this domain that an independent regulator, registry or peer-reviewed venue names, listed alphabetically. Being listed is a record, not a recommendation.
- SC301의원 · Seoulnamed by an authority 3
References
- Level C · organizationFat Transfer Breast Augmentation — American Society of Plastic Surgeons · Evidence page
- Level C · organizationFat Transfer Breast Augmentation Risks and Safety — American Society of Plastic Surgeons · Evidence page
- Level B · journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract record — BMC Cancer (via Europe PMC) · Evidence page
- Level B · journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64) — Seminars in Plastic Surgery (Thieme) via PubMed Central · Evidence page
- Level B · journalCell-Assisted Lipotransfer in Breast Augmentation Surgery: Clinical Outcomes and Considerations for Future Research — Cureus (via PubMed Central) · Evidence page